Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | GGT1 | P19440 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
| ▸ | ODC1 | P11926 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GNPAT | O15228 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735 | 1.00 | FOLH1 (0.46) | FOLH1CPB2GSRRNPEPMMP2 | |
| SCHEMBL2873029 | 1.00 | FOLH1 (0.46) | FOLH1CPB2GSRRNPEPMMP2 | |
| Hydrochloric Acid SCHEMBL1560135 | 0.98 | FOLH1 (0.45) | FOLH1CPB2GSRRNPEPMMP2 | |
| Hydrochloric Acid SCHEMBL1560136 | 0.98 | FOLH1 (0.45) | FOLH1CPB2GSRRNPEPMMP2 | |
| Hydrochloric Acid SCHEMBL21933053 | 0.96 | FOLH1 (0.44) | FOLH1CPB2GSRRNPEPMMP2 | |
| SCHEMBL6479470 | 0.94 | FOLH1 (0.53) | FOLH1CPB2GSRRNPEPMMP2 | |
| SCHEMBL6479474 | 0.94 | FOLH1 (0.53) | FOLH1CPB2GSRRNPEPMMP2 | |
| Ornithine SCHEMBL3820639 | 0.91 | GSR (0.56) | FOLH1GSR | |
| Benzoquinone SCHEMBL28214836 | 0.88 | FOLH1 (0.39) | FOLH1CPB2GSRRNPEPMMP2 | |
| SCHEMBL7203447 | 0.85 | FOLH1 (0.44) | FOLH1CPB2GSRRNPEPMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18390 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-12569488-B2 | Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients | POLARIS PHARMACEUTICALS, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4694909-A1 | METHODS OF MODULATING THE EPITHELIAL-MESENCHYMAL TRANSITION | RS Oncology, LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4687999-A1 | TROP2 CONJUGATED BIOLOGICAL MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | OBI Pharma, Inc. (TW) | 2026-02-11 | — | — | EP | claimed |
| EP-4676544-A1 | ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODIES AGAINST HUMAN L1CAM AND USES THEREOF | LigaChem Biosciences Inc. (KR) | 2026-01-14 | — | — | EP | claimed |
| EP-4673533-A1 | METHODS OF TREATING CANCERS | Polaris Pharmaceuticals Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| US-12478685-B2 | Methods and kits for identifying subjects responsive to arginine deprivation therapy | POLARIS PHARMACEUTICALS. INC. (US) | 2025-11-25 | — | — | US | claimed |
| EP-4618967-A1 | COMBINATION OF POLYAMINE PATHWAY INHIBITOR DRUG AND PROLINE/ARGININE DIET RESTRICTION | Universität Zürich (CH) | 2025-09-24 | — | — | EP | claimed |
| US-20250275938-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | SCIROSBIO LIMITED (AE) | 2025-09-04 | — | — | US | claimed |
| EP-0863990-A1 | USE OF ANTI-SENSE SEQUENCES TO INCREASE RESPONSIVENESS TO GENE AMPLIFICATION | INTERPHARM LABORATORIES LTD. (IL) | 1998-09-16 | — | — | EP | claimed |
| WO-1997020055-A1 | USE OF ANTI-SENSE SEQUENCES TO INCREASE RESPONSIVENESS TO GENE AMPLIFICATION | INTERPHARM LABORATORIES LTD. (IL) | 1997-06-05 | — | — | WO | claimed |
| US-5629045-A | Biodegradable nosiogenic agents for control of non-vertebrate pests | Veech, Richard L. (US) | 1997-05-13 | — | — | US | claimed |
| US-5585243-A | SEPARATELY INCUBATING HUMAN PLATELETS WITH BLOOD SAMPLE ANDREAGENT DRUG SOLUTION TO FORM COMPLEXES, DETERMINING AMOUNT OF BOUND ANTIBODY | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1996-12-17 | — | — | US | claimed |
| US-5455161-A | Determining levels of ornithine decarboxylase activity; drug sensitivity; immunoassay | TECHNICON RESEACH & DEVELOPMENT FOUNDATION LTD. (IL) | 1995-10-03 | — | — | US | claimed |
| WO-1995008116-A1 | METHOD OF DETECTING CYTOPENIA THAT IS MEDIATED BY DRUG-DEPENDENT ANTIBODY BINDING TO BLOOD CELLS | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1995-03-23 | — | — | WO | claimed |
| US-5002879-A | Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor | MERRELL DOW PHARMACEUTICALS (US) | 1991-03-26 | — | — | US | claimed |
| US-4925835-A | INHIBITING PROLIFERATION OF CANCER CELLS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1990-05-15 | — | — | US | claimed |
| US-4859452-A | ADMINISTERING MIXTURE OF AMINO ACID AND POLYAMINE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-08-22 | — | — | US | claimed |
| US-4751348-A | USING ULTRAVIOLET LIGHT MUTAGEN, POLYAMINE SYNTEHSIS INHIBITORS, AND GROWTH IN THE DARK | COLD SPRING HARBOR LABORATORY (US) | 1988-06-14 | — | — | US | claimed |